Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer

Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer

Background Regulatory T (Treg) cells play a negative role in anti-tumor immunity against triple-negative breast cancer, so it is of great significance to find the potential therapeutic target of Treg cells.Methods First, Annexin A1 (ANXA1) expression and survival of patients with breast cancer were...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bin Li, Peng Zhang, Dan li, Fang Bai, Yipeng Fu, Hongliang Chen, Mingdi Zhang, Qianru Huang, Kejin Wu
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-05-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/8/1/e000169.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ADAM12 abrogation alters immune cell infiltration and improves response to checkpoint blockade therapy in the T11 murine model of triple-negative breast cancer
by: Guanpeng Wang, et al.
Published: (2023-12-01)

METTL14 suppresses the expression of YAP1 and the stemness of triple-negative breast cancer
by: Xupeng Bai, et al.
Published: (2024-11-01)

Tripartite motif-containing protein 50 suppresses triple-negative breast cancer progression by regulating the epithelial–mesenchymal transition
by: Danxiang Chen, et al.
Published: (2024-12-01)

Targeting the NLRP3 inflammasome abrogates cardiotoxicity of immune checkpoint blockers
by: Ping Li, et al.
Published: (2025-01-01)

The analysis of gene co-expression network and immune infiltration revealed biomarkers between triple-negative and non-triple negative breast cancer
by: Yao Yi, et al.
Published: (2025-01-01)

Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020-09-01)

Identification of ANXA1 as a Novel Upstream Negative Regulator of Notch1 Function in AML
by: Gang Shao, et al.
Published: (2024-12-01)

Intra-tumoral sphingobacterium multivorum promotes triple-negative breast cancer progression by suppressing tumor immunosurveillance
by: Zhikai Mai, et al.
Published: (2025-01-01)

DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities
by: Wen-yu Cai, et al.
Published: (2025-02-01)

Glycosylation profiling of triple-negative breast cancer: clinical and immune correlations and identification of LMAN1L as a biomarker and therapeutic target
by: Qianru Yu, et al.
Published: (2025-01-01)

Correction: Intra-tumoral sphingobacterium multivorum promotes triple-negative breast cancer progression by suppressing tumor immunosurveillance
by: Zhikai Mai, et al.
Published: (2025-01-01)

Tumor microenvironment and immunotherapy for triple-negative breast cancer
by: Zijie Guo, et al.
Published: (2024-12-01)

Advances in the Understanding of the Pathogenesis of Triple‐Negative Breast Cancer
by: Yuhan Liu, et al.
Published: (2024-11-01)

Clinical Characteristics in Patients with Triple Negative Breast Cancer
by: Janet Yeh, et al.
Published: (2017-01-01)

Natural products as part of triple negative breast cancer
by: Yozlem Kobakova, et al.
Published: (2025-01-01)

Triple-Negative Breast Cancer: Tumor Immunogenicity and Beyond
by: Elio Ibrahim, et al.
Published: (2024-01-01)

Classifications of triple-negative breast cancer: insights and current therapeutic approaches
by: Ziqi Chen, et al.
Published: (2025-02-01)

TMEM132E ablation suppresses tumor progression and restores tamoxifen sensitivity by inducing ERα expression in triple-negative breast cancer
by: Shang Gao, et al.
Published: (2025-03-01)

Immune environment of high-TIL breast cancer: triple negative and hormone receptor positive HER2 negative
by: Su-Jin Shin, et al.
Published: (2024-11-01)

Tabersonine enhances cisplatin sensitivity by modulating Aurora kinase A and suppressing epithelial–mesenchymal transition in triple-negative breast cancer
by: Xi Chen, et al.
Published: (2024-12-01)

The prognostic marker KRT81 is involved in suppressing CD8 + T cells and predicts immunotherapy response for triple-negative breast cancer
by: Zhideng Yan, et al.
Published: (2024-12-01)

Outcome for Patients with Triple-Negative Breast Cancer Is Not Dependent on Race/Ethnicity
by: Quyen D. Chu, et al.
Published: (2012-01-01)

Intrinsic subtype and immunity score in identification of triple-negative breast cancer at low risk
by: Xinyu Ren, et al.
Published: (2025-04-01)

Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality
by: Noor A. M. Bakker, et al.
Published: (2025-01-01)

Platycodon grandiflorum-derived extracellular vesicles suppress triple-negative breast cancer growth by reversing the immunosuppressive tumor microenvironment and modulating the gut microbiota
by: Min Yang, et al.
Published: (2025-02-01)

The overview of modern approaches in treatment of triple negative breast cancer
by: A. A. Kharitonova, et al.
Published: (2020-03-01)

Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy
by: Parvin F. Peddi, et al.
Published: (2012-01-01)

Endothelial Cells Potentially Participate in the Metastasis of Triple-Negative Breast Cancer
by: Yanfei Ma, et al.
Published: (2022-01-01)

CRISPR/Cas9-mediated RELA and RELC knockout in human regulatory T cells abrogates FOXP3 expression and suppressive function
by: Yohei Sato, et al.
Published: (2024-12-01)

Prognostic model based on tumor stemness genes for triple-negative breast cancer
by: Min Ouyang, et al.
Published: (2024-12-01)

Transcriptomic analysis reveals potential crosstalk genes and immune relationship between triple-negative breast cancer and depression
by: Zhili Zhuo, et al.
Published: (2024-12-01)

Circulating immune cell dynamics in patients with triple negative breast cancer treated with neoadjuvant chemotherapy
by: Sarah Talamantes, et al.
Published: (2020-10-01)

Targeting PRMT5 through PROTAC for the treatment of triple-negative breast cancer
by: Yaxun Guo, et al.
Published: (2024-11-01)

Synthesis of Zinc Oxide-Doped Carbon Dots for Treatment of Triple-Negative Breast Cancer
by: Wang M, et al.
Published: (2024-12-01)

Dual Inhibition of CDK4/6 and CDK7 Suppresses Triple‐Negative Breast Cancer Progression via Epigenetic Modulation of SREBP1‐Regulated Cholesterol Metabolism
by: Yilan Yang, et al.
Published: (2025-02-01)

Unlocking the epigenetic code: new insights into triple-negative breast cancer
by: Gowthami Mahendran, et al.
Published: (2024-12-01)

Identification of ERBB Pathway-Activated Cells in Triple-Negative Breast Cancer
by: Soo Young Cho
Published: (2019-03-01)

Metabolic Syndrome and Triple-Negative Breast Cancer: A New Paradigm
by: Andrew A. Davis, et al.
Published: (2012-01-01)

Heterogeneity of anoikis in triple-negative breast cancer subtyping and therapeutic implications
by: Kun Fang, et al.
Published: (2025-01-01)

Identification and validation of neutrophils-related subtypes and prognosis model in triple negative breast cancer
by: Shanqi Li, et al.
Published: (2024-03-01)